
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (08): 948-954.DOI: 10.12114/j.issn.1007-9572.2023.0278
• Original Research • Previous Articles Next Articles
Received:2023-04-15
Revised:2023-07-12
Published:2024-03-15
Online:2023-12-19
Contact:
ZHANG Li
通讯作者:
张莉
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0278
| 组别 | 例数 | 年龄( | 性别[例(%)] | BMI ( | 主要诊断[例(%)] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 呼吸系统疾病 | 循环系统疾病 | 中枢神经系统疾病 | 消化系统疾病 | 泌尿系统疾病 | 其他 | ||||
| 压力性损伤组 | 22 | 71.3±6.1 | 13(59.1) | 9(40.9) | 23.3±1.7 | 15(68.2) | 1(4.5) | 3(13.6) | 0 | 1(4.5) | 2(9.2) |
| 非压力性损伤组 | 137 | 60.5±9.3 | 79(57.7) | 58(42.3) | 23.1±1.8 | 98(71.5) | 0 | 29(21.2) | 0 | 2(1.5) | 8(5.8) |
| 检验统计量值 | 3.960a | 0.413b | 0.259a | 6.376b | |||||||
| P值 | <0.001 | 0.563 | 0.796 | 0.173 | |||||||
| 组别 | 脓毒症[例(%)] | 糖尿病[例(%)] | 总住院时间[M(P25,P75),d] | ICU住院时间[M(P25,P75),d] | APACHEⅡ[M(P25,P75),分] | NRS 2002[M(P25,P75),分] | Braden评分[M(P25,P75),分] | 单次俯卧位时间( | |||
| 是 | 否 | 是 | 否 | ||||||||
| 压力性损伤组 | 8(36.4) | 14(63.6) | 17(77.3) | 5(22.7) | 21(20,23) | 16(15,17) | 16(11,19) | 4(4,5) | 11(10,12) | 13.6±2.9 | |
| 非压力性损伤组 | 10(7.3) | 127(92.7) | 38(27.7) | 99(72.3) | 20(18,23) | 13(11,15) | 14(11,18) | 4(4,5) | 11(10,12) | 6.6±2.0 | |
| 检验统计量值 | 2.419b | 10.550b | 1.364 | 3.274 | 0.635 | 0.810 | 0.468 | 11.025a | |||
| P值 | 0.139 | 0.001 | 0.173 | 0.001 | 0.526 | 0.418 | 0.681 | <0.001 | |||
| 组别 | 总俯卧位时间( | 平均动脉压( | 镇静[例(%)] | RASS [M(P25,P75),分] | 机械通气方式[例(%)] | 营养方式[例(%)] | |||||
| 是 | 否 | 有创机械通气 | 无创机械通气 | 高流量鼻导管氧疗 | 肠内营养 | 肠外营养 | |||||
| 压力性损伤组 | 71.5±4.2 | 66.8±7.4 | 22(100.0) | 0 | -4(-3,-4) | 15(68.2) | 0 | 7(31.8) | 18(81.8) | 4(18.2) | |
| 非压力性损伤组 | 70.9±4.2 | 65.9±7.2 | 137(100.0) | 0 | -2(-3,-1) | 117(85.4) | 0 | 20(14.6) | 127(92.7) | 10(7.3) | |
| 检验统计量值 | 2.932a | 0.854a | -4.154 | 4.729b | 0.485b | ||||||
| P值 | 0.004 | 0.429 | <0.001 | 0.030 | 0.486 | ||||||
| 组别 | 连续血液净化治疗[例(%)] | IABP治疗[例(%)] | 去甲肾上腺素剂量( | PaO2/FiO2 ( | 血乳酸( | 白蛋白( | 血红蛋白( | 静脉血葡萄糖( | |||
| 是 | 否 | 是 | 否 | ||||||||
| 压力性损伤组 | 12(54.5) | 10(45.5) | 3(13.6) | 19(86.4) | 0.7±0.1 | 139.5±23.9 | 2.4±0.9 | 33.7±3.0 | 99.0±14.8 | 12.1±1.6 | |
| 非压力性损伤组 | 25(18.3) | 112(81.7) | 5(3.6) | 132(96.4) | 0.3±0.1 | 212.4±21.4 | 2.8±0.9 | 33.7±2.7 | 104.5±14.4 | 13.3±2.6 | |
| 检验统计量值 | 2.921b | 10.831b | 14.161a | -11.248a | -1.699a | -1.238a | -1.269a | -1.647a | |||
| P值 | 0.087 | 0.001 | <0.001 | <0.001 | 0.091 | 0.238 | 0.206 | 0.102 | |||
Table 1 Comparison of baseline data between the two groups
| 组别 | 例数 | 年龄( | 性别[例(%)] | BMI ( | 主要诊断[例(%)] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | 呼吸系统疾病 | 循环系统疾病 | 中枢神经系统疾病 | 消化系统疾病 | 泌尿系统疾病 | 其他 | ||||
| 压力性损伤组 | 22 | 71.3±6.1 | 13(59.1) | 9(40.9) | 23.3±1.7 | 15(68.2) | 1(4.5) | 3(13.6) | 0 | 1(4.5) | 2(9.2) |
| 非压力性损伤组 | 137 | 60.5±9.3 | 79(57.7) | 58(42.3) | 23.1±1.8 | 98(71.5) | 0 | 29(21.2) | 0 | 2(1.5) | 8(5.8) |
| 检验统计量值 | 3.960a | 0.413b | 0.259a | 6.376b | |||||||
| P值 | <0.001 | 0.563 | 0.796 | 0.173 | |||||||
| 组别 | 脓毒症[例(%)] | 糖尿病[例(%)] | 总住院时间[M(P25,P75),d] | ICU住院时间[M(P25,P75),d] | APACHEⅡ[M(P25,P75),分] | NRS 2002[M(P25,P75),分] | Braden评分[M(P25,P75),分] | 单次俯卧位时间( | |||
| 是 | 否 | 是 | 否 | ||||||||
| 压力性损伤组 | 8(36.4) | 14(63.6) | 17(77.3) | 5(22.7) | 21(20,23) | 16(15,17) | 16(11,19) | 4(4,5) | 11(10,12) | 13.6±2.9 | |
| 非压力性损伤组 | 10(7.3) | 127(92.7) | 38(27.7) | 99(72.3) | 20(18,23) | 13(11,15) | 14(11,18) | 4(4,5) | 11(10,12) | 6.6±2.0 | |
| 检验统计量值 | 2.419b | 10.550b | 1.364 | 3.274 | 0.635 | 0.810 | 0.468 | 11.025a | |||
| P值 | 0.139 | 0.001 | 0.173 | 0.001 | 0.526 | 0.418 | 0.681 | <0.001 | |||
| 组别 | 总俯卧位时间( | 平均动脉压( | 镇静[例(%)] | RASS [M(P25,P75),分] | 机械通气方式[例(%)] | 营养方式[例(%)] | |||||
| 是 | 否 | 有创机械通气 | 无创机械通气 | 高流量鼻导管氧疗 | 肠内营养 | 肠外营养 | |||||
| 压力性损伤组 | 71.5±4.2 | 66.8±7.4 | 22(100.0) | 0 | -4(-3,-4) | 15(68.2) | 0 | 7(31.8) | 18(81.8) | 4(18.2) | |
| 非压力性损伤组 | 70.9±4.2 | 65.9±7.2 | 137(100.0) | 0 | -2(-3,-1) | 117(85.4) | 0 | 20(14.6) | 127(92.7) | 10(7.3) | |
| 检验统计量值 | 2.932a | 0.854a | -4.154 | 4.729b | 0.485b | ||||||
| P值 | 0.004 | 0.429 | <0.001 | 0.030 | 0.486 | ||||||
| 组别 | 连续血液净化治疗[例(%)] | IABP治疗[例(%)] | 去甲肾上腺素剂量( | PaO2/FiO2 ( | 血乳酸( | 白蛋白( | 血红蛋白( | 静脉血葡萄糖( | |||
| 是 | 否 | 是 | 否 | ||||||||
| 压力性损伤组 | 12(54.5) | 10(45.5) | 3(13.6) | 19(86.4) | 0.7±0.1 | 139.5±23.9 | 2.4±0.9 | 33.7±3.0 | 99.0±14.8 | 12.1±1.6 | |
| 非压力性损伤组 | 25(18.3) | 112(81.7) | 5(3.6) | 132(96.4) | 0.3±0.1 | 212.4±21.4 | 2.8±0.9 | 33.7±2.7 | 104.5±14.4 | 13.3±2.6 | |
| 检验统计量值 | 2.921b | 10.831b | 14.161a | -11.248a | -1.699a | -1.238a | -1.269a | -1.647a | |||
| P值 | 0.087 | 0.001 | <0.001 | <0.001 | 0.091 | 0.238 | 0.206 | 0.102 | |||
| 变量 | 逐步Logistic回归模型 | 全变量Logistic回归模型 | Lasso-Logistic回归模型 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 年龄 | 39.041(8.772~73.754) | 0.004 | 26.882(2.246~92.809) | 0.005 | 38.256(4.728~109.551) | <0.001 |
| 糖尿病 | 7.256(1.873~28.104) | 0.025 | 1.770(1.050~62.266) | 0.046 | 1.094(1.035~11.357) | 0.004 |
| ICU住院时间 | 2.610(1.194~35.184) | 0.006 | ||||
| 单次俯卧位时间 | 6.705(1.503~29.904) | 0.001 | 5.340(1.395~72.107) | 0.033 | 5.738(1.640~51.425) | 0.038 |
| 总俯卧位时间 | 1.152(0.721~1.840) | 0.119 | ||||
| RASS | 0.238(0.054~1.046) | 0.096 | 1.179(1.047~1.679) | 0.031 | ||
| 有创机械通气 | 0.528(0.132~2.105) | 0.539 | ||||
| 高流量鼻导管氧疗 | 1.894(0.475~7.551) | 0.404 | ||||
| 血液净化治疗 | 2.480(0.142~43.242) | 0.765 | ||||
| IABP | 4.086(0.084~98.346) | 0.621 | ||||
| 去甲肾上腺素 | 1.588(0.045~7.774) | 0.412 | ||||
| PaO2/FiO2 | 0.997(0.603~1.081) | 0.968 | ||||
| 血乳酸 | 0.999(0.975~1.064) | 0.970 | ||||
Table 2 Three Logistic regression models of prone position ventilation-related facial pressure injuries
| 变量 | 逐步Logistic回归模型 | 全变量Logistic回归模型 | Lasso-Logistic回归模型 | |||
|---|---|---|---|---|---|---|
| OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
| 年龄 | 39.041(8.772~73.754) | 0.004 | 26.882(2.246~92.809) | 0.005 | 38.256(4.728~109.551) | <0.001 |
| 糖尿病 | 7.256(1.873~28.104) | 0.025 | 1.770(1.050~62.266) | 0.046 | 1.094(1.035~11.357) | 0.004 |
| ICU住院时间 | 2.610(1.194~35.184) | 0.006 | ||||
| 单次俯卧位时间 | 6.705(1.503~29.904) | 0.001 | 5.340(1.395~72.107) | 0.033 | 5.738(1.640~51.425) | 0.038 |
| 总俯卧位时间 | 1.152(0.721~1.840) | 0.119 | ||||
| RASS | 0.238(0.054~1.046) | 0.096 | 1.179(1.047~1.679) | 0.031 | ||
| 有创机械通气 | 0.528(0.132~2.105) | 0.539 | ||||
| 高流量鼻导管氧疗 | 1.894(0.475~7.551) | 0.404 | ||||
| 血液净化治疗 | 2.480(0.142~43.242) | 0.765 | ||||
| IABP | 4.086(0.084~98.346) | 0.621 | ||||
| 去甲肾上腺素 | 1.588(0.045~7.774) | 0.412 | ||||
| PaO2/FiO2 | 0.997(0.603~1.081) | 0.968 | ||||
| 血乳酸 | 0.999(0.975~1.064) | 0.970 | ||||
| 模型 | 区分度 | 校准度 | ||||
|---|---|---|---|---|---|---|
| AUC | 灵敏度 | 特异度 | AIC | BIC | R2 | |
| 逐步Logistic回归 | 0.771 | 0.959 | 0.583 | 46.564 | 64.327 | 0.681 |
| 全变量Logistic回归 | 0.736 | 0.973 | 0.500 | 51.876 | 67.220 | 0.692 |
| Lasso-Logistic回归 | 0.855 | 0.959 | 0.750 | 44.634 | 55.745 | 0.721 |
Table 3 Predictive efficacy of different Logistic regression models
| 模型 | 区分度 | 校准度 | ||||
|---|---|---|---|---|---|---|
| AUC | 灵敏度 | 特异度 | AIC | BIC | R2 | |
| 逐步Logistic回归 | 0.771 | 0.959 | 0.583 | 46.564 | 64.327 | 0.681 |
| 全变量Logistic回归 | 0.736 | 0.973 | 0.500 | 51.876 | 67.220 | 0.692 |
| Lasso-Logistic回归 | 0.855 | 0.959 | 0.750 | 44.634 | 55.745 | 0.721 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
金珊珊,俞戈,谢晖,等. 基于LASSO回归的重症急性胰腺炎患者肺炎克雷伯杆菌感染风险预测模型建立[J]. 中华胰腺病杂志,2023,23(1):20-27. DOI:10.3760/cma.j.cn115667-20221010-00154.
|
| [24] |
秦瑶,韩红娟,陈杜荣,等. 基于LASSO logistic回归模型的轻度认知障碍逆转预测模型[J]. 中国卫生统计,2022,39(5):653-658. DOI:10.3969/j.issn.1002-3674.2022.05.003.
|
| [25] |
黄娅,李运明,雷丽. Lasso Logistic回归模型识别脂肪肝风险因素效果研究[J]. 甘肃科学学报,2021,33(4):45-51. DOI:10.16468/j.cnki.issn1004-0366.2021.04.008.
|
| [1] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [2] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| [3] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [4] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [5] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [6] | ZHEN Rui, GU Xufang, GAO Shengwei, ZHANG Bowen, REN Zhenjuan, YANG Ruixuan. Burden of Cardiovascular Diseases Attributable to Metabolic Risk Factors in China 1990—2021 and Projected Trends from 2022 to 2035 [J]. Chinese General Practice, 2026, 29(15): 2077-2083. |
| [7] | LIU Tianyuan, SANG Wanyue, PENG Jiping, CHENG Siyi, HUANG Yiyi, LI Ouwen, JIANG Hong, ZHOU Xiaoya. Correlation Analysis between Neurofilament Light Chain and the Risk of Left Ventricular Hypertrophy in Patients with Nocturnal Hypertension [J]. Chinese General Practice, 2026, 29(15): 2014-2021. |
| [8] | ZHANG Yaping, ZHAO Xuhao, PANG Ting, HE Xindi, YUAN Changzheng, WEN Xu, LIU Zuyun, XU Xin. Association between Health Physical Fitness and Successful Aging among Middle-aged and Elderly Adults in the Community [J]. Chinese General Practice, 2026, 29(13): 1706-1712. |
| [9] | YUAN Weixia, AO Panpan, MA Yun, WU Fengfu, XU Facui, YU Juan, ZENG Qun, WEI Shaofeng, YUAN Lijia. The Predictive Value of Age-adjusted Charlson Comorbidity Index for Sarcopenia in Older Adults [J]. Chinese General Practice, 2026, 29(13): 1673-1681. |
| [10] | HU Jiaqi, LI Duan, FANG Hao, FAN Xingying, DU Wei, ZHOU Hanni. Study on Predictive Model of Non-genetic Risk Factors for Hyperuricemia in a Physical Examination Cohort [J]. Chinese General Practice, 2026, 29(10): 1324-1333. |
| [11] | LEI Yingying, ZHENG Siying, WANG Wenxin, JIANG Hong. Prevalence Trend and Prediction of Hypertensive Heart Disease in the World and China from 1990 to 2021 [J]. Chinese General Practice, 2026, 29(05): 641-648. |
| [12] | WANG Biyou, GAO Ying, YOU Junfang, LIU Li, ZHANG Qing, SU Haiyan. Canonical Correlation Analysis of Lipid Ratios and Inflammatory Markers in Individuals at Risk of Cardiovascular Disease [J]. Chinese General Practice, 2025, 28(33): 4132-4139. |
| [13] | LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu. Interpretation of Report on Cardiovascular Health and Diseases in China 2024 [J]. Chinese General Practice, 2025, 28(32): 3989-4008. |
| [14] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
| [15] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||